Steven Cohen's CMPX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 686,577 shares of Compass Therapeutics, Inc. (CMPX) worth $1.5 M, representing 0.00% of the portfolio. First purchased in 2023-Q1, this short-term holding has been held for 3 quarters.
Based on 13F filings, Steven Cohen has maintained this position in CMPX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 686,577 shares. Largest reduction occurred in Q2 2023, reducing 1,528 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Compass Therapeutics (CMPX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Compass Therapeutics (CMPX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +686,577 | New Buy | 686,577 | $2.19 |
| Q2 2023 | -1,528 | Sold Out | 0 | $0.00 |
| Q1 2023 | +1,528 | New Buy | 1,528 | $3.27 |
Steven Cohen's Compass Therapeutics Investment FAQs
Steven Cohen first purchased Compass Therapeutics, Inc. (CMPX) in Q1 2023, acquiring 1,528 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Compass Therapeutics, Inc. (CMPX) for 3 quarters since Q1 2023.
Steven Cohen's largest addition to Compass Therapeutics, Inc. (CMPX) was in Q2 2026, adding 686,577 shares worth $1.5 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 686,577 shares of Compass Therapeutics, Inc. (CMPX), valued at approximately $1.5 M.
As of the Q2 2026 filing, Compass Therapeutics, Inc. (CMPX) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Compass Therapeutics, Inc. (CMPX) was 686,577 shares, as reported at the end of Q2 2026.